APA

Locatelli F., Whitlock J. A., Peters C., Chen-Santel C., Chia V., Dennis R. M., Heym K. M., Katz A. J., Kelsh M. A., Sposto R., Tu H., Tuglus C. A., Verma A., Vinti L., Wilkes J. J., Zubarovskaja N., Zugmaier G., von Stackelberg A. & Sun W. (20201118). Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia. : Leukemia.

Chicago

Locatelli Franco, Whitlock James A, Peters Christina, Chen-Santel Christiane, Chia Victoria, Dennis Robyn M, Heym Kenneth M, Katz Aaron J, Kelsh Michael A, Sposto Richard, Tu Huakang, Tuglus Catherine A, Verma Anupam, Vinti Luciana, Wilkes Jennifer J, Zubarovskaja Nathalya, Zugmaier Gerhard, von Stackelberg Arend and Sun Weili. 20201118. Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia. : Leukemia.

Harvard

Locatelli F., Whitlock J. A., Peters C., Chen-Santel C., Chia V., Dennis R. M., Heym K. M., Katz A. J., Kelsh M. A., Sposto R., Tu H., Tuglus C. A., Verma A., Vinti L., Wilkes J. J., Zubarovskaja N., Zugmaier G., von Stackelberg A. and Sun W. (20201118). Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia. : Leukemia.

MLA

Locatelli Franco, Whitlock James A, Peters Christina, Chen-Santel Christiane, Chia Victoria, Dennis Robyn M, Heym Kenneth M, Katz Aaron J, Kelsh Michael A, Sposto Richard, Tu Huakang, Tuglus Catherine A, Verma Anupam, Vinti Luciana, Wilkes Jennifer J, Zubarovskaja Nathalya, Zugmaier Gerhard, von Stackelberg Arend and Sun Weili. Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia. : Leukemia. 20201118.